Enanta Pharmaceuticals





Ebitda Cambiamento Data
AbbVie USD 3.52B 828M 2025-09
Amgen USD 5.14B 775M 2025-12
Anika Therapeutics USD -2.69M 4.73M 2025-03
Arrowhead Research USD 64.2M 223.53M 2025-09
AstraZeneca USD 5.23B 272M 2025-09
Biogen USD 573.2M 253.7M 2025-12
Bristol-Myers Squibb USD 4.24B 967M 2025-09
Gilead Sciences USD 4.03B 628M 2025-09
GlaxoSmithKline GBP 3.36B 179M 2025-09
Halozyme Therapeutics USD 248.25M 22.74M 2025-09
Heron Therapeutics USD -3.88M 5.63M 2024-09
Immunic USD -22.78M 753K 2024-06
Incyte USD 506.92M 74.6M 2025-09
Insmed USD -297.13M 71.11M 2025-06
Ionis Pharmaceuticals USD -157.12M 307.36M 2025-09
J&J USD 9.52B 389M 2025-09
Karyopharm Therapeutics USD -26.2M 1.83M 2024-09
Ligand Pharmaceuticals USD 20.9M 61.44M 2025-06
Merck USD 8.39B 1.97B 2025-09
Neurocrine Biosciences USD 246.7M 93.8M 2025-09
Novartis USD 5.88B 290M 2025-09
Novavax USD -117.12M 55.66M 2024-09
Pfizer USD 6.08B 351M 2025-09
PTC Therapeutics USD -33.11M 1B 2025-06
Roche Holding CHF 12.68B 2.36B 2024-06
Sarepta Therapeutics USD 126.42M 416.82M 2025-06
Vertex Pharmaceuticals USD 1.44B 100.4M 2025-09


Enanta Pharmaceuticals - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.